These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 11384100
1. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas. Shimada S, Shiomori K, Tashima S, Tsuruta J, Ogawa M. Br J Cancer; 2001 Jun 01; 84(11):1497-504. PubMed ID: 11384100 [Abstract] [Full Text] [Related]
2. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci. Shiomori K, Shimada S, Marutsuka T, Hatayama I, Ogawa M. Int J Oncol; 2003 Jan 01; 22(1):65-74. PubMed ID: 12469186 [Abstract] [Full Text] [Related]
4. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas. Tashima S, Shimada S, Yamaguchi K, Tsuruta J, Ogawa M. Am J Gastroenterol; 2000 Jan 01; 95(1):255-63. PubMed ID: 10638593 [Abstract] [Full Text] [Related]
5. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T. J Gastroenterol Hepatol; 2000 Oct 01; 15(10):1151-7. PubMed ID: 11106095 [Abstract] [Full Text] [Related]
9. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Itoi T, Watanabe H, Ajioka Y, Oohashi Y, Takel K, Nishikura K, Nakamura Y, Horil A, Saito T. Pathol Int; 1996 May 01; 46(5):333-40. PubMed ID: 8809879 [Abstract] [Full Text] [Related]
10. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T, Yokozaki H, Shimamoto F, Haruma K, Yasui W, Kajiyama G, Tahara E. J Pathol; 1998 Oct 01; 186(2):131-9. PubMed ID: 9924427 [Abstract] [Full Text] [Related]
12. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M. Cancer Res; 1994 Sep 01; 54(17):4798-804. PubMed ID: 8062281 [Abstract] [Full Text] [Related]
13. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Gastroenterology; 1995 Feb 01; 108(2):434-40. PubMed ID: 7835585 [Abstract] [Full Text] [Related]
17. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY. Am Surg; 2005 Apr 01; 71(4):336-43. PubMed ID: 15943410 [Abstract] [Full Text] [Related]
18. Histological and genetic changes in malignant transformation of gallbladder adenoma. Watanabe H, Date K, Itoi T, Matsubayashi H, Yokoyama N, Yamano M, Ajioka Y, Nishikura K. Ann Oncol; 1999 Apr 01; 10 Suppl 4():136-9. PubMed ID: 10436806 [Abstract] [Full Text] [Related]
19. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma. Linsalata M, Notarnicola M, Caruso MG, Di Leo A, Guerra V, Russo F. Scand J Gastroenterol; 2004 May 01; 39(5):470-7. PubMed ID: 15180186 [Abstract] [Full Text] [Related]
20. Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis. Matsuzaki H, Shimada S, Uno K, Tsuruta J, Ogawa M. Am J Clin Pathol; 1998 Feb 01; 109(2):181-9. PubMed ID: 9583890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]